Retraction Watch: Exclusive: Journal bans drug safety database papers as they flood the literature. “Starting around 2023, a curious trend took hold in papers on drug safety monitoring. The number of articles published on an individual drug and its link to specific adverse events went from a steady increase to a huge spike. The data source in most of those articles was largely the same: The FDA […]

https://rbfirehose.com/2025/09/17/exclusive-journal-bans-drug-safety-database-papers-as-they-flood-the-literature-retraction-watch/